FDA Approves MYCOPHENOLATE MOFETIL — Ascend Laboratories, LLC

Ascend Laboratories has received FDA approval for its generic version of CellCept (mycophenolate mofetil) to prevent organ transplant rejection. This ANDA approval introduces a new market option for the immunosuppressant, potentially increasing competition and lowering costs for physicians and patients.